The Impact of Thrombus Aspiration on 1-year Mortality in Primary PCI for ST-Elevation Myocardial Infarction, ACSIS 2010 Experience Mady Moriel, Shlomi.

Slides:

Advertisements

Similar presentations

A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction.

Advertisements

The EMERALD Trial Diabetic Substudy. EMERALD Diabetic Analysis To compare myocardial perfusion and infarct sizes in diabetic and non-diabetic patients.

Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:

Gregg W. Stone MD for the ACUITY Investigators Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary.

Comparison of AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients with Acute Myocardial Infarction: the JETSTENT trial David.

Comparison of AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients with Acute Myocardial Infarction: the JETSTENT trial David.

Multivessel coronary disease diagnosed at the time of primary PCI for STEMI: complete revascularization versus conservative strategy. PRAGUE 13 trial O.

on behalf of the TOTAL Investigators

TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.

STEMI Due to Stent Thrombosis: An Enlarging Subgroup of High Risk Patients Bruce Brodie, Adam Bensimhon, Nathan Fleishman, Charles Hansen, Mike Cooper,

University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.

Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.

Francesco Liistro Cardiovascular Department, Arezzo, Italy Impact of Thrombus Aspiration on Myocardial Tissue Reperfusion and Left Ventricular Functional.

Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,

Prehospital Fibrinolysis with Double Antiplatelet Therapy in Acute ST-Elevation Myocardial Infarction: The Clarity Ambulance Substudy Prehospital Fibrinolysis.

Effect of Postconditioning on Myocardial Reperfusion during Primary Percutaneous Coronary Intervention Joo-Yong Hahn / Hyeon-Cheol Gwon On behalf of the.

Presentation at a Non PCI Facility Requiring Transfer Does NOT Worsen Long-term Prognosis in Patients With STEMI Undergoing Primary Angioplasty. The HORIZONS-AMI.

Athens Cardiology Update CADILLAC Study Blood Transfusion after Myocardial Infarction: Friend, Foe or double-edged Sword? Georgios I. Papaioannou,

Improving outcome of STEMI PCI: Preliminary Results of Crystal AMI trial Rajesh M. Dave, MD Principal investigator on behalf of Crystal AMI Investigators.

Myocardial Ischaemia National Audit Project Are we replacing good fibrinolytic treatment with poor primary PCI? John Birkhead who has NO CONFLICT OF INTEREST.

比伐卢定在 STEMI 中的应用价值王乐丰首都医科大学附属北京朝阳医院心脏中心. Goals of STEMI PCI Establish reperfusion of IRA ASAP Limit complications Limit costs Achieve excellent long.

Beyond TIMI 3 Flow CTFC < 14 CTFC > % (n=41) (n = 18/640) (n =35/563) 2.8% p= “TIMI 4” Flow TIMI 3 Flow 14 < CTFC < % % Risk of In Hospital.

Baseline Characteristics Current or Former Smoker Diabetic Hypertension 25.7 Prior MI Prior Heart Failure.

Correlation between post-PTCA resolution of ST segment and mortality in STEMI patients First author: Diana Opincariu Co-authors: Carmen Moldovan Daniel.

The Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented.

UNIVERSITÄT LEIPZIG H E R Z Z E N T R U M Infarct transmurality and infarct size assessed by delayed enhancement magnetic resonance imaging: Association.

CARDIOLOGIA INV 1 CAREGGI - FIRENZE Objective To determine whether nonresponsiveness to clopidogrel as revealed by high in vitro residual platelet reactivity.

Academic Medical Center Amsterdam Interventional Cardiology Koch TCT 2008 A Prospective Randomized Trial of Proximal Microcirculatory Protection in Patients.

Paclitaxel Eluting Stent Versus Conventional Stent in ST-segment Elevation Myocardial Infarction (PASSION) Trial Presented at The American College of Cardiology.

Secondary prevention of a Recurrent ACS; Results from the 2004 & 2006 ACSIS Survey Perl L, Behar S, Schwartz R, Mosseri M Meir Hospital and Sheba Tel Hashomer,

Keith Dawkins MD FRCP FACC Southampton University Hospital UK Is Primary Angioplasty Equally Effective in Both Men and Women ?

New strategies and perfusion/aspiration devices for primary PCI Sandra Garcia Cruset, PhD. Cordynamic B.U. Marketing Manager.

Trial Vignettes 1-3 Mark Mason Harefield Hospital Royal Brompton and Harefield NHS Trust.

VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.

Gregg W. Stone MD for the ACUITY Investigators Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary.

The MASTER Trial A Prospective, Randomized, Multicenter Evaluation of a PET Micronet Mesh Covered Stent (MGuard) in STEMI Sigmund Silber, MD, PhD FESC,

Thrombus aspiration versus conventional primary PCI in STEMI patients V. Mironov Russian Cardiology Research Center 2014.

Gregg W. Stone MD for the ACUITY Investigators A Prospective, Randomized Trial of Bivalirudin in Acute Coronary Syndromes Final One-Year Results from the.

Impact Of Diabetes Mellitus On The Safety And Effectiveness Of Bivalirudin In Patients With Acute Myocardial Infarction Undergoing Primary Angioplasty:

Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.

Assessment of the Safety and Efficacy of a New Treatment Strategy for Acute Myocardial Infarction (ASSENT-4 PCI) Trial ASSENT- 4 PCI Trial Presented at.

M-Guard stent in STEMI patients with high thrombus burden lesions Mahmoud Shabestari Baktash Bayani Ali Eshraghi Bahram Shahri Mashhad University.

Dartmouth Hitchcock Medical Center

Stent Thrombosis Rates in Contemporary Clinical Practice: Insight from a Large Australian Multi-centre Registry BP Yan*, TJ Kiernan, SJ Duffy, DJ Clark,

On behalf of J. Belardi, M. Leon, L. Mauri,

Circ Cardiovasc Interv

ATLANTIC Trial design: Participants with STEMI being transported for primary PCI were randomized in the ambulance to ticagrelor 180 mg (n = 909) vs. placebo.

The American College of Cardiology Presented by Dr. Maurits T. Dirksen

European Heart Association Journal 2007 April

European Society of Cardiology 2003

Recent Temporal Trends in the Presentation, Management, and Outcome of Women Hospitalized with Acute Coronary Syndromes Avi Sabbag, MD, Shlomi Matetzky,

Figure 2 Ischaemic and bleeding outcomes in the major clinical trials

Giuseppe Biondi Zoccai, MD

The HORIZONS-AMI Trial

Figure 1 PCI strategies in patients with STEMI and multivessel disease

Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors During Elective Coronary Revascularization A meta-analysis of randomized trials performed in the.

Impact of clopidogrel loading dose on the safety and effectiveness of bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction:

American Heart Association Presented by Dr. Julinda Mehilli

Impact of Platelet Reactivity Following Clopidogrel Administration

Mancini JG, et al. Am J Cardiol.

What oral antiplatelet therapy would you choose?

Nat. Rev. Cardiol. doi: /nrcardio

Efficacy and Safety of Glycoprotein IIb/IIIa Inhibitors During Elective Coronary Revascularization A meta-analysis of randomized trials performed in the.

Impact of Diabetes Mellitus on Long-term Outcomes in the

Maintenance of Long-Term Clinical Benefit with

MRRs and EMRRs for women with ACS

A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.

Ticagrelor versus prasugrel; risk ratio with 95% CIs for the primary composite end point, primary composite end point in those undergoing PCI, myocardial.

Sex Differences in the Management and 5-Year Outcome of Young Patients (

Adjusted. ORs for outcomes by maintenance P2Y12 treatment

Presentation transcript:

The Impact of Thrombus Aspiration on 1-year Mortality in Primary PCI for ST-Elevation Myocardial Infarction, ACSIS 2010 Experience Mady Moriel, Shlomi Matetzky, Amit Segev, Aharon Medina, Ran Kornowski, Haim Danenberg, Natalie Gevrielov-Yusim, Ilan Goldenberg, Dan Tzivoni, Shmuel Gottlieb for ACSIS and ACSIS-PCI Investigators 60th International Conference of the Israel Heart Society April 2013, Jerusalem

There are no financial relationships to disclose.

Background Prior studies have suggested that thrombus aspiration (TA) in pts with STEMI undergoing PPCI may reduce 1-yr mortality. Aim To assess the impact of TA in consecutive STEMI pts undergoing PPCI on 1-yr mortality. Methods 517 STEMI pts who underwent PPCI in 23 centers during ACSIS 2010 were included. Results Pts who underwent TA-PPCI vs. conventional (C)-PPCI were of similar age and had similar risk factors and history of coronary disease.

TA-PPCI (n=217) C-PPCI (n=300)P Radial access (%) Multivessel disease (%) LAD-IRA (%) Culprit lesion ostial-proximal(%) Time from symptom onset to reperfusion (min; median,Q1,Q3) 195 (130,317)188 (131,330)0.78 TIMI flow 0-1 before PPCI (%)8056< Restoration of flow after guidewire3252< IIb/IIIa inhibitors use (%)6949< TIMI flow 3, end of PPCI (%) Myocardial blush 3, end of PCI (%) ST segment resolution 1 st ECG after PCI (%) Drug Eluting Stent (n,%) Hospital Complications, 1-y mortality (%) No reflow Major bleeding Acute renal failure TIA/stroke year mortality (n, %)(8/217) 3.7(20/299) Angiographic and PPCI Results, Complications and 1-year Mortality

Variables Independently Associated with use of TA OR95% CIP Center < TIMI 0, < Use of IIa/IIIb GP inhibitors Diabetes p Hazard Ratio (95% CI) < ( )Killip Class > ( )MBG<3 < ( )Age ( )Use of Aspiration ( )Use of IIb/IIIa Predictors of 1-year mortality 3.7% %7. 7

Conclusions In the "real-world," practice use of TA in STEMI patients undergoing P-PPCI is associated with improved 1-year mortality